Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-12-07

FDA Approved: EXFORGE HCT — Supplemental Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

The FDA approved a supplemental application for Exforge HCT (amlodipine/valsartan/hydrochlorothiazide) submitted by Novartis Pharmaceuticals Corporation. The ap…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Exforge HCT (amlodipine/valsartan/hydrochlorothiazide)

Snippet

SUPPL AP for EXFORGE HCT (AMLODIPINE VALSARTAN AND HYDROCHLOROTHIAZIDE)